Ensign Peak Advisors
CDMO

Ensign Peak Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Ensign Peak Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-11,460
Closed -$219K – 2266
2022
Q3 		$219K Buy
11,460
+2,550
+29% +$46.5K ﹤0.01% 1847
2022
Q2 		$136K Hold
8,910
– – ﹤0.01% 1904
2022
Q1 		$181K Hold
8,910
– – ﹤0.01% 1899
2021
Q4 		$260K Buy
+8,910
New +$255K ﹤0.01% 1859

Other funds holding CDMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Ensign Peak Advisors's CDMO Position: Q4 2022 in Review

Ensign Peak Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 11,460 shares — an estimated $219K sold.

Ensign Peak Advisors first reported a position in CDMO in Q4 2021 and held it in 4 quarters. The position peaked at $260K in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

  • Ensign Peak Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Ensign Peak Advisors sold 11,460 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $219K.
  • Ensign Peak Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Ensign Peak Advisors's Avid Bioservices, Inc. Common Stock position peaked at $260K in Q4 2021.
  • 168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Ensign Peak Advisors's 13F filing for Q4 2022, filed 13 Feb 2023.